In conclusion, although INF2‐related CMT is relatively rare in Japan, it should be considered in pediatric patients with demyelinating neuropathy and early‐onset renal dysfunction, particularly if CIDP is suspected. This evidence concerns the gene INF2 and Abnormal renal physiology.